ClearPoint Neuro, Inc. (CLPT) Misses Q2 EPS by 10c ; offers Guidance

ClearPoint Neuro, Inc. (NASDAQ: CLPT) reported Q2 EPS of ($0.29), $0.10 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $6 million versus the consensus estimate of $5.9 million.

GUIDANCE:

ClearPoint Neuro, Inc. sees FY2023 revenue of $25-27 million, versus the consensus of $26 million.

For earnings history and earnings-related data on ClearPoint Neuro, Inc. (CLPT) click here.

You May Also Be Interested In

• Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
• Clearpoint Neuro Inc. (CLPT) PT Raised to $25 at Stifel
• Pfizer reaffirms 2026 guidance after CFO transition news